re: + + phase ii, nsclc trial + + Extract:
"We have seen positive signs in the PI-88 Phase I single agent trial where over 40% of the melanoma patients showed tumor growth retarded for periods lasting up
to 30 months
and from the Phase II multiple myeloma trial where 39% of patients have shown cancer stabilization for periods up to 2 years".
Comment: These are highly significant results. And as far as I know the first meaningful result of any Melanoma cancer trial.
Melanoma is a most dreaded disease and treatment agents fear to tread in this field.
Phase I was very succesfull and if Phase II is, then there is a possibility that some concessions can be obtained from the FDA.
And what about selling this drug if proven successful?
At this stage, there would be a big demand for it IMHO.
Gerry
Readers, please do your own research and you decide if and when to buy, hold or sell any stocks.
- Forums
- ASX - By Stock
- PGL
- + + data and comments + +
+ + data and comments + +, page-12
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PGL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online